Balanced news tone
News Sentiment
E1WL34 sentiment intelligence
Edwards Lifesciences Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+8.4% over one week, +12.0% over four weeks, trend inactive, and near fair-value range.
Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 14:15
- Source
- Investing.com Nigeria
A Look at Edwards Lifesciences Corp (EW) After 3.1% Decline -- G
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Jul 2026 21:57
- Source
- GuruFocus
Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 11 Jul 2026 00:46
- Source
- GuruFocus
Form 4 Edwards Lifesciences Corp For: 10 July By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 21:43
- Source
- Investing.com South Africa
Edwards Lifesciences CVP sells $56,762 in company stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 21:34
- Source
- Investing.com
Edwards Lifesciences’ SWOT analysis: stock gains momentum on market share opportunity
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Investing.com
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- PR Newswire
Edwards Lifesciences stock hits 52-week high at 92.94 USD By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 13:42
- Source
- Investing.com Canada
TD Cowen Names Edwards Lifesciences as Top Medical Device Pick
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Investing.com
What You Need To Know Ahead of Edwards Lifesciences' Earnings Release
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 07:00
- Source
- Barchart.com
Edwards Lifesciences stock hits 52-week high at 89.7 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com
Edwards Lifesciences CEO Zovighian sells $45,982 of stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Investing.com
Leerink reiterates Edwards Lifesciences stock rating on TAVR policy
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 07:00
- Source
- Investing.com
Edwards Lifesciences stock jumps on TAVR coverage proposal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Investing.com
Edwards Lifesciences stock hits 52-week high at $89.50 By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at 87.89 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Investing.com
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Barchart.com
Edwards Lifesciences CVP, TAVR, sells $170,160 in stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Investing.com
TD Cowen reiterates Edwards Lifesciences stock rating on TAVR strength
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 17 Apr 2026 07:00
- Source
- Investing.com
US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jan 2026 08:00
- Source
- Reuters